dc.contributor.author |
John, Scott
|
|
dc.contributor.author |
Walwyn, David Richard
|
|
dc.contributor.author |
DeFea, Kathryn
|
|
dc.contributor.author |
Hales, Tim G.
|
|
dc.contributor.author |
Walwyn, Wendy
|
|
dc.date.accessioned |
2024-06-21T09:28:24Z |
|
dc.date.available |
2024-06-21T09:28:24Z |
|
dc.date.issued |
2023-07-14 |
|
dc.description.abstract |
No abstract available. |
en_US |
dc.description.department |
Graduate School of Technology Management (GSTM) |
en_US |
dc.description.librarian |
am2024 |
en_US |
dc.description.sdg |
SDG-03:Good heatlh and well-being |
en_US |
dc.description.uri |
http://www.frontiersin.org/Pharmacology |
en_US |
dc.identifier.citation |
John, S., Walwyn, D.R., DeFea, K., Hales, T.G. & Walwyn, W. (2023), Editorial: Opioids
in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy. Frontiers in Pharmacology 14:1251958. DOI: 10.3389/fphar.2023.1251958. |
en_US |
dc.identifier.issn |
1663-9812 (online) |
|
dc.identifier.other |
10.3389/fphar.2023.1251958 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/96591 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Frontiers Media |
en_US |
dc.rights |
© 2023 John, Walwyn, DeFea, Hales and
Walwyn. This is an open-access article
distributed under the terms of the
Creative Commons Attribution License
(CC BY). |
en_US |
dc.subject |
Opioid use disorder |
en_US |
dc.subject |
Substance use disorder |
en_US |
dc.subject |
Opioid use disorder treatment |
en_US |
dc.subject |
Substance use disorder treatment |
en_US |
dc.subject |
COVID-19 pandemic |
en_US |
dc.subject |
Coronavirus disease 2019 (COVID-19) |
en_US |
dc.subject |
SDG-03: Good health and well-being |
en_US |
dc.subject |
Editorial |
en_US |
dc.title |
Editorial : Opioids in the time of the COVID-19 pandemic : from cellular mechanisms to public health policy |
en_US |
dc.type |
Article |
en_US |